Gastrointestinal pirfenidone adverse events in idiopathic pulmonary fibrosis depending on diet: the MADIET clinical trial.

Address: Interstitial Lung Disease Unit, Respiratory Department, University Hospital of Bellvitge, Research Lab 4126, IDIBELL, UB, Barcelona, Spain [email protected].; Spanish Research Network in Respiratory Diseases (CIBERES), Barcelona, Spain.; Interstitial Lung Disease Unit, Respiratory Department, University Hospital of Bellvitge, Research Lab 4126, IDIBELL, UB, Barcelona, Spain.; NIHR Manchester Clinical Research Facility, Interstitial Lung Disease Unit, Respiratory Medicine Department, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.; Laboratory of Cellular and Molecular Pneumonology, Dept of Respiratory Medicine, School of Medicine, University of Crete, Heraklion, Greece.; Center for Interstitial and Rare Lung Diseases, Ruhrlandklinik, University Hospital, University of Duisburg Essen, Essen, Germany.; NIHR Respiratory Clinical Research Facility, Royal Brompton Hospital, and Fibrosis Research Group, National Heart and Lung Institute, Imperial College, London, UK.; Exeter Respiratory Institute, University of Exeter and Royal Devon University Hospitals NHS Foundation Trust, Exeter, UK.; Keck Medicine of University of Southern California, Los Angeles, CA, USA.; National Heart and Lung Institute, Imperial College, London, UK.; Dept of Clinical and Experimental Medicine, Regional Referral Centre for Rare Lung Diseases, University Hospital "Policlinico G. Rodolico - San Marco", University of Catania, Catania, Italy.; Unit of Nutritional Support, University Hospital of Vall d'Hebron, Barcelona, Spain.; Dept of Biostatistics, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.; Dept of Clinical Laboratory, Bellvitge University Hospital, IDIBELL, Barcelona, Spain.; Dept of Respiratory Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands.